{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:33:23Z","timestamp":1781782403414,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":782,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jtct.2020.10.023","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T14:05:07Z","timestamp":1609423507000},"page":"310.e1-310.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma"],"prefix":"10.1016","volume":"27","author":[{"given":"Aimee M.","family":"Merino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohtesh S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"De For","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Janakiram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Wangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cichocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Bachanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2020.10.023_bib0001","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bbmt.2008.04.013","article-title":"Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study","volume":"14","author":"Porrata","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0002","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1705342","article-title":"Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma","volume":"37","author":"Joao","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0003","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/1078-0432.1210.11.3","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis","volume":"11","author":"Porrata","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2020.10.023_bib0004","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.leu.2402503","article-title":"Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia","volume":"16","author":"Porrata","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2020.10.023_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1703236","article-title":"Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer","volume":"28","author":"Porrata","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.10.023_bib0007","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbmt.2014.03.007","article-title":"Lymphocyte subset recovery and outcome after autologous hematopoietic stem cell transplantation for plasma cell myeloma","volume":"20","author":"Rueff","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0008","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1046\/j.1365-2141.2002.03478.x","article-title":"Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease","volume":"117","author":"Porrata","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.10.023_bib0009","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1704355","article-title":"Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma","volume":"33","author":"Porrata","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5500\/wjt.v7.i4.235","article-title":"Lymphocyte recovery is an independent predictor of relapse in allogeneic hematopoietic cell transplantation recipients for acute leukemia","volume":"7","author":"Damlaj","year":"2017","journal-title":"World J Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0011","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3109\/10428194.2013.783912","article-title":"Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndrome","volume":"54","author":"Chang","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2020.10.023_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3349\/ymj.2013.54.1.62","article-title":"Implication of early lymphocyte recovery after allogeneic hematopoietic stem cell transplantation in children with leukemia","volume":"54","author":"Han","year":"2013","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jtct.2020.10.023_bib0013","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbmt.2010.08.022","article-title":"Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies","volume":"17","author":"Burke","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0014","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/bmt.2010.306","article-title":"Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT","volume":"46","author":"B\u00fchlmann","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0015","doi-asserted-by":"crossref","first-page":"e86252","DOI":"10.1172\/jci.insight.86252","article-title":"Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide","volume":"1","author":"Kanakry","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2020.10.023_bib0016","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.bbmt.2016.09.006","article-title":"Early natural killer cell reconstitution predicts overall survival in T cell-replete allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Minculescu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0017","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1182\/blood-2004-10-4113","article-title":"NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect","volume":"105","author":"Nguyen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.10.023_bib0018","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood-2011-04-347070","article-title":"NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions","volume":"118","author":"Foley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.10.023_bib0019","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1070884","article-title":"Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors","volume":"296","author":"Arase","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jtct.2020.10.023_bib0020","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1060042","article-title":"Vital involvement of a natural killer cell activation receptor in resistance to viral infection","volume":"292","author":"Brown","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jtct.2020.10.023_bib0021","doi-asserted-by":"crossref","first-page":"8826","DOI":"10.1073\/pnas.092258599","article-title":"Recognition of a virus-encoded ligand by a natural killer cell activation receptor","volume":"99","author":"Smith","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtct.2020.10.023_bib0022","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jtct.2020.10.023_bib0023","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI125916","article-title":"Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming","volume":"129","author":"Merino","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtct.2020.10.023_bib0024","first-page":"9.50.1","article-title":"Identification of human memory-like NK cells","volume":"79","author":"Kovalenko","year":"2017","journal-title":"Curr Protoc Cytom"},{"key":"10.1016\/j.jtct.2020.10.023_bib0025","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2016-08-734285","article-title":"Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs","volume":"129","author":"Corat","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.10.023_bib0026","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood-2016-08-734236","article-title":"Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells","volume":"129","author":"Schlums","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.10.023_bib0027","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1158\/0008-5472.CAN-16-0839","article-title":"Adaptive NK cells with low TIGIT expression are inherently resistant to myeloid-derived suppressor cells","volume":"76","author":"Sarhan","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtct.2020.10.023_bib0028","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/2326-6066.CIR-17-0498","article-title":"Adaptive NK cells resist regulatory T-cell suppression driven by IL37","volume":"6","author":"Sarhan","year":"2018","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jtct.2020.10.023_bib0029","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12885-019-5529-0","article-title":"Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients","volume":"19","author":"Amini","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtct.2020.10.023_bib0030","first-page":"9133","article-title":"Functional role of regulatory T cells in B cell lymphoma and related mechanisms","volume":"8","author":"Wu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jtct.2020.10.023_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.blre.2016.04.002","article-title":"Myeloid-derived suppressor cells: the green light for myeloma immune escape","volume":"30","author":"Malek","year":"2016","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2020.10.023_bib0032","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12935-018-0687-8","article-title":"Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study","volume":"18","author":"Wang","year":"2018","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jtct.2020.10.023_bib0033","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2002.03879.x","article-title":"Anti-myeloma activity of natural killer lymphocytes","volume":"119","author":"Frohn","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.10.023_bib0034","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05286.x","article-title":"Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application","volume":"128","author":"Hayashi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.10.023_bib0035","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2020.10.023_bib0036","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125553","article-title":"Adaptive NK cell reconstitution is associated with better clinical outcomes","volume":"4","author":"Cichocki","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jtct.2020.10.023_bib0037","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3324\/haematol.2014.113415","article-title":"Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation","volume":"100","author":"Itzykson","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.10.023_bib0038","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbmt.2005.07.008","article-title":"Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection","volume":"11","author":"Gallez-Hawkins","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.10.023_bib0039","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","article-title":"Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013","volume":"88","author":"Mikhael","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jtct.2020.10.023_bib0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0038-1634034","article-title":"Scoring and staging systems using Cox linear regression modeling and recursive partitioning","volume":"45","author":"Lee","year":"2006","journal-title":"Methods Inf Med"},{"key":"10.1016\/j.jtct.2020.10.023_bib0041","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1541-0420.2010.01493.x","article-title":"Competing risks regression for stratified data","volume":"67","author":"Zhou","year":"2011","journal-title":"Biometrics"},{"key":"10.1016\/j.jtct.2020.10.023_bib0042","article-title":"Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas","volume":"2010","author":"Porrata","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.jtct.2020.10.023_bib0043","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.14570","article-title":"Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma","volume":"177","author":"Shah","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.10.023_bib0044","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00262-015-1694-4","article-title":"Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A","volume":"64","author":"Sarkar","year":"2015","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jtct.2020.10.023_bib0045","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Gum\u00e1","year":"2004","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:00:13Z","timestamp":1763002813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636720300488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2666636720300488"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2020.10.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2020.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}